These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3240964)

  • 1. Application of 1H-nuclear magnetic resonance spectroscopic method for quinidine to simultaneous determination of quinidine and dihydroquinidine in quinidine sulfate tablets.
    Hanna GM; Lau-Cam CA
    J Assoc Off Anal Chem; 1988; 71(6):1118-21. PubMed ID: 3240964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A stability-indicating proton nuclear magnetic resonance spectroscopic method for the analysis of propantheline bromide in pharmaceutical samples.
    Hanna GM; Lau-Cam CA
    Pharmazie; 2001 Sep; 56(9):700-3. PubMed ID: 11593989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear magnetic resonance spectroscopic determination of dicyclomine hydrochloride in tablet, capsule, and injection dosage forms.
    Hanna GM
    J Assoc Off Anal Chem; 1984; 67(2):222-4. PubMed ID: 6725188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydroquinidine contamination of quinidine raw materials and dosage forms: rapid estimation by high-performance liquid chromatography.
    Narang PK; Crouthamel WG
    J Pharm Sci; 1979 Jul; 68(7):917-9. PubMed ID: 458617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton magnetic resonance spectroscopic method for determination of phenylbutazone and oxyphenbutazone in tablets.
    Husain S; Kifayatullah M; Rao RN
    J Assoc Off Anal Chem; 1988; 71(3):525-7. PubMed ID: 3391955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of quinidine, dihydroquinidine, (3S)-3-hydroxyquinidine and quinidine N-oxide in plasma and urine by high-performance liquid chromatography.
    Nielsen F; Nielsen KK; Brøsen K
    J Chromatogr B Biomed Appl; 1994 Oct; 660(1):103-10. PubMed ID: 7858702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton magnetic resonance spectroscopic determination of bethanechol chloride in tablets.
    Hanna GM; Lau-Cam CA
    J Assoc Off Anal Chem; 1987; 70(3):557-9. PubMed ID: 2886488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Cinchona alkaloids by high-performance liquid chromatography. Application to the analysis of quinidine gluconate and quinidine sulfate and their dosage forms.
    Smith E
    J Chromatogr; 1984 Sep; 299(1):233-44. PubMed ID: 6490780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton magnetic resonance spectroscopic determination of disulfiram: collaborative study.
    Sheinin EB; Benson WR
    J Assoc Off Anal Chem; 1978 Jan; 61(1):55-9. PubMed ID: 621194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro electrophysiology of quinidine, its major metabolites and dihydroquinidine.
    Thompson KA; Blair IA; Woosley RL; Roden DM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):84-90. PubMed ID: 3572799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate analysis of nuclear magnetic resonance data--characterization of critical drug substance quality of gentamicin sulfate.
    Winter W; Deubner R; Holzgrabe U
    J Pharm Biomed Anal; 2005 Aug; 38(5):833-9. PubMed ID: 16087045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid high-pressure liquid chromatographic determination of quinidine and dihydroquinidine in plasma samples.
    Kates RE; McKennon DW; Comstock TJ
    J Pharm Sci; 1978 Feb; 67(2):269-70. PubMed ID: 621655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption of quinidine and dihydroquinidine in humans.
    Hailey DM; Lea AR; Coles DM; Heaume PE; Smith WJ
    Eur J Clin Pharmacol; 1981; 21(3):195-9. PubMed ID: 7318878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bioavailability and kinetics of dihydroquinidine in patients with heart disease.
    Regazzi Bonora M; Salerno JA; Rondanelli R; Cristiani D; Chimienti M
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):212-8. PubMed ID: 7095920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-state bioavailability of two sustained-release quinidine preparations: quinidine gluconate versus quinidine sulfate.
    Taggart WV; Holyoak W
    Clin Ther; 1983; 5(4):357-64. PubMed ID: 6871920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of enalapril by 1H NMR spectroscopy in tablets.
    Zoppi A; Linares M; Longhi M
    J Pharm Biomed Anal; 2005 Mar; 37(3):627-30. PubMed ID: 15740927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinidine and dihydroquinidine interactions in human plasma.
    Ueda CT; Makoid MC
    J Pharm Sci; 1979 Apr; 68(4):448-50. PubMed ID: 438966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dihydroquinidine on in vitro and in vivo quinidine disposition.
    Ueda CT
    Biochem Pharmacol; 1980 Mar; 29(5):737-40. PubMed ID: 20227949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effectiveness of dihydroquinidine and quinidine on ventricular ectopy after acute and chronic administration.
    Chimienti M; Regazzi MB; La Rovere MT; Salerno JA; Previtali M; Montericcio V; Rondanelli R; Montemartini C
    Cardiovasc Drugs Ther; 1988 Dec; 2(5):679-86. PubMed ID: 2484920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of quinidine, its major metabolites, and dihydroquinidine in patients with torsades de pointes.
    Thompson KA; Murray JJ; Blair IA; Woosley RL; Roden DM
    Clin Pharmacol Ther; 1988 Jun; 43(6):636-42. PubMed ID: 3378385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.